Clinical trial
Clinical Evaluation of the Safety and Feasibility of the Ethmoid Sinus Spacer and Access System With Drug (SPACER)
NCT01054703 is registered in ClinicalTrials.gov with Integra LifeSciences Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of the Safety and Feasibility of the Ethmoid Sinus Spacer and Access System With Drug (SPACER)
- Lead sponsor
- Integra LifeSciences Corporation
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- April 1, 2007
- Completion date
- November 1, 2007
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sinusitis, chronic rhinosinusitis